Does breast-feeding increase the risk of transmission of the hepatitis B virus chronic carrier state?;L'allaitement accroit-il le risque de transmission de l'etat de porteur chronique du virus de l'hepatite B?

Gastroenterologie Clinique et Biologique

Volumn 21, Issue 3, 1997, Pages 197-199

  Soulié, Jean Claude ^a   Uzan, Michèle ^a  

^a HÔPITAL JEAN VERDIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B VACCINE;

BREAST FEEDING; CONTAMINATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; PREVENTION; SHORT SURVEY; VACCINATION; VIRUS TRANSMISSION; ADULT; CHRONIC DISEASE; DISEASE TRANSMISSION; FEMALE; HETEROZYGOTE; MALE; NEWBORN; REVIEW; RISK FACTOR;

ADULT; BREAST FEEDING; CARRIER STATE; CHRONIC DISEASE; FEMALE; HEPATITIS B; HUMANS; INFANT, NEWBORN; MALE; RISK FACTORS;

EID: 0031000472     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (37)

1. Cunningham AS, Jelliffe DB, Jellilfe EFP. Breast-feeding and health in the 1980s. A global epidemiologic review. J Pediatr 1991;118:659-66.
2. Denis F, Tabuste JR, Ranger-Rogez S. Prévalence de l'AgHBs ehez près de 21500 femmes enceintes. Enquête de douze C.H.U. français. BEH 1994;12:53-4.
3. Roudot-Thoraval F, Kouadja F, Wirquin V, Thiers V, Avons P, Brćchot C, et al. Prévalence du portage de l'antigène HBs et des marqueurs de réplication virale B dans une population de femmes enceintes, en France. Gastroenterol Clin Biol 1989;13:353-6.
4. Soulié JC, Goudeau A, Larsen M, Parnet F, Dubois F, Pinon F, et al. Prévention de la transmission périnatale du virus de l'hépatite B. Epidémiologie et rapport coût/efficacité dans la région de Paris. Presse Med 1991;20:939-44.
5. Mason J. Breast-feeding in 1991. N Engl J Med 1991;325:1036-7.
6. Black RF. Transmission of HIV-1 in the breast-feeding process. J Am Diet Assoc 1996;96:267-74.
7. Zanetti AR, Tanzi E, Paccagnini S, Principi N, Pizzocolo G, Caccamo ML, et al. Mother-to-infant transmission of hepatitis C virus. Lancet 1995;1:289-91.
8. Hirata M, Hayashi J, Noguchi A, Nakashima K, Kajiyama W, Kashiwagi S, et al. The effects of breastfeeding and presence of antibody to p40tax protein of human T-cell lymphotropic virus type-I on mother to child transmission. Int J Epidemiol 1992;21:989-94.
9. Chin J. Prevention of chronic hepatitis B virus infection from mothers to infants in the United States. Pediatrics 1983;71:289-92.
10. Pearce N, Milne A, Moyes C, Hepatitis B virus: the importance of age at infection. N Z Med J 1988;101:788-90.
11. Okada K, Kamiyuma I, Inomata M, Imai M, Miyakawa Y, Mayumi M. e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N Engl J Med 1976;294:746-9.
12. Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975;292:771-4.
13. Stevens CE, Neurath RA, Beasley RP, Szmuness W. HBeAg and anti-HBe detection by radio-immunoassay: correlation with vertical transmission of hepatitis B virus in Taiwan. J Med Virol 1979,3:237-41.
14. Barin F, Perin J, Chotard J, Denis F, N'Doye R, Diop Mar I, et al. Cross-sectional and longitudinal epidemiology of hepatitis B in Senegal. Prog Med Virol 1981;27:148-62.
15. Burk RD, Hwang LY, Ho GYF, Shafritz DA, Beasley RP. Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load. J Infect Dis 1994:170:1418-23.
16. Lee AKY, Ip HMH, Wong VCW. Mechanisms of malernal-fetal transmission of hepatitis B virus. J Infect Dis 1978;138:668-71.
17. Brossard Y, Pons JC, Jrad I, Van Nifterik J, Gillot R, Saure C, et al. Maternal-fetal hemorrage: a reappraisal. Vox Sang 1996;71:103-7.
18. Lee SD, Lo KJ, Tsai YT, Wu JC, Wu TC, Yang HT. Role of ceasarean section in prevention of mother-infant transmission of hepatitis B virus. Lancet 1988;2:833-4.
19. Schulm SW, Pit-Grosheide P. Prevention of hepatitis B transmission at birth. Lancet 1989;1:44.
20. Beasley RP, Hwang LY, Slevens CE, Lin CC, Hsieh FJ, Wang KY, et al. Efficacy of hepatitis B immune globulin (HBIG) for prevention of perinatal transmission of the HBV carrier state: final report of a randomised double-blind placebo-controlled trial. Hepatology 1983;3:135-41.
21. Poovorawan Y, Sanpavat S, Pongpunlert W, Chumdermpadetsuk S, Sentrakul A, Salary A. Protective efficacy of a recombinant DNA vaccine in neonates of HBe antigen-positive mothers. JAMA 1989,261:3278-81.
22. Anonymous. Recommendations of the Immunization Practices Advisory Committee. Prevention of prenatal transmission of hepatitis B virus: prenatal screening of all women for hepatitis B surface antigen. MMWR 1988;37:341-51.
23. Bégué P, Roure C. Vaccination contre l'hépatite des enfants nés de mères antigène HBs positif. BEH 1991;49:213-4.
24. Chan GCB, Yeoh EK, Young B, Chang WK, Lim WL, Lin HJ. Effects of pregnancy on the hepatitis B carrier state. In: Hollinger FB, Lemon SM, Margolis H, eds. International symposium on viral hepatitis and liver disease. Houston: Williams & Wilkins, 1990:678-80.
25. Lin HH, Hsu HY, Chang MH, Chen PJ, Chen DS. Hepatitis B virus in the colostra of HBeAg-positive carrier mothers. J Pediatr Gastroenterol Nutr 1993;17:207-10.
26. Beasley RP, Stevens CE, Shiao IS, Meng HC. Evidence against breast-feeding as a mechanism for vertical transmission of hepatitis B. Lancet 1975;2:740-1.
27. Soulié JC, Devillier P, Santarelli J, Goudeau A, Vermeulen P, Guellier M, et al. Immunogenicity and safety in newborns of a new recombinant hepatitis-B vaccine containing the S and preS2 antigens. Vaccine 1991;9:545-8.
28. Anonymous. Immunisation against hepatitis B. Lancet 1988;1:875-6.
29. Wong VCW, Ip HMH, Reesink HW, Lelie PN, Reerink-Brongers EE, Yeung CY, et al. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study. Lancet 1984;1:921-6.
30. Stevens CE, Toy PT, Tong MJ, Taylor PE, Vyas GN. Perinatal hepatitis B transmission in the United States: prevention by passive-active immunization. JAMA 1985;253:1740-5.
31. Stevens CE, Taylor PE, Tong MJ, Toy PT. Yeast-recombinant hepatitis B vaccine: efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission. JAMA 1987;257:2612-6.
32. Schalm SW, Mazel JA, De Gast GC, Heijtink RA, Botman MJ, Bänffer JRJ, et al. Prevention of hepatitis B infection in newborns through mass screening and delayed vaccination of all infants of mothers with hepatitis B surface antigen. Pediatrics 1989;83:1041-7.
33. Soulié JC, Goudeau A, Parnet F. Brossard Y, Dubois F, Huchet J. Séro-vaccination des nouveau-nés de mères porteuses chroniques de l'antigène HBs, Elude multicentrique comparative de l'immunogénicité et de l'efficacité de doses normales et de doses réduites du vaccin Hevac B. Rech Gynecol 1990;2:25-30.
34. De Martino M, Appendino C, Rossi ME, Muccioli AT, Vierucci A. Should hepatitis B surface antigen mothers breast feed ? Arch Dis Child 1985;60:972-4.
35. Tseng RYM, Lam CWK, Tam J. Breastfeeding babies of HBsAg-positive mothers. Lancet 1988;2:1032.
36. Ip HMH, Lelie PN, Wong VCW, Kuhns MC, Reesink HW. Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA. Lancet 1989;1:406-10.
37. Marion SA, Pasture MT, Pi DW, Mathias RG. Long-term follow-up of hepatitis B vaccine in infants of carrier mothers. Am J Epidemiol 1994;140:734-46.